The role of respiratory viruses in cystic fibrosis

Dennis Wat1, Colin Gelder2, Sam Hibbitts3

  • 1Department of Cystic Fibrosis, University Hospital of Wales, Cardiff, UK.

Insights

Respiratory viruses significantly increase cystic fibrosis (CF) exacerbations, with upper respiratory symptoms being key indicators. Advanced detection methods improve clinical decision-making for CF patients.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Genetics and Genomics

Background:

  • Previous research indicates respiratory viruses may worsen cystic fibrosis (CF) exacerbations.
  • Conventional diagnostic methods may underestimate the true impact of viral infections in CF.

Purpose of the Study:

  • To investigate the association between respiratory viruses and CF exacerbations.
  • To evaluate the utility of Nucleic Acid Sequence Based Amplification (NASBA) in detecting viruses during CF exacerbations.

Main Methods:

  • Collected nasal swabs and sputum from children with CF during routine visits and exacerbations.
  • Utilized Nucleic Acid Sequence Based Amplification (NASBA) for respiratory virus detection.
  • Defined respiratory exacerbations based on symptom scores, peak expiratory flow, or parental subjective assessment.

Main Results:

  • Respiratory viruses were detected in 46% of exacerbation samples, compared to 16.9% in asymptomatic samples.
  • Influenza A, influenza B, and rhinovirus were significantly more prevalent during exacerbations.
  • Upper respiratory symptoms strongly correlated with positive viral detection, suggesting viral exacerbations can be independent of bacterial infections.

Conclusions:

  • Respiratory viruses are linked to CF exacerbations, with upper respiratory symptoms as strong predictors.
  • 'Real-time' NASBA offers rapid results, potentially aiding clinical decisions regarding antiviral and antibiotic treatments.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...